コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 erative setting to improve outcomes for this vulnerable population.
2 ctly measure coronary artery disease in this vulnerable population.
3 er reduce and eliminate SHS exposure in this vulnerable population.
4 fy the neurodevelopmental trajectory in this vulnerable population.
5 alth of adolescents and young adults in this vulnerable population.
6 F) levels measured before SE identified this vulnerable population.
7 er antibody testing and vaccination for this vulnerable population.
8 for more effective vaccines to protect this vulnerable population.
9 e lack of effective vaccines for use in this vulnerable population.
10 ctive adjuvant for vaccines targeted to this vulnerable population.
11 new vaccines with improved efficacy for this vulnerable population.
12 effective pain management strategies in this vulnerable population.
13 signed to support clinicians caring for this vulnerable population.
14 ood deprivation in a highly mobile, socially vulnerable population.
15 Annual vaccination is merited in this vulnerable population.
16 measures to prevent COVID-19 spread in this vulnerable population.
17 rategies for augmenting host defence in this vulnerable population.
18 ate assessment and treatment of pain in this vulnerable population.
19 purine-metabolizing enzymes may benefit this vulnerable population.
20 ight-loss trials systematically exclude this vulnerable population.
21 t are suitably adapted for the needs of this vulnerable population.
22 ve management of major complications in this vulnerable population.
23 sely examined the effects of being part of a vulnerable population.
24 nary approach to optimize management of this vulnerable population.
25 duce long-term cardiovascular events in this vulnerable population.
26 ch is essential to improve outcomes for this vulnerable population.
27 care, and end-of-life care of this frail and vulnerable population.
28 atment and preventive interventions for this vulnerable population.
29 itial guidance on dosing oseltamivir in this vulnerable population.
30 clarify the endocrine effects of BPA on this vulnerable population.
31 the quality provision of healthcare for this vulnerable population.
32 5 years for informing expanded usage in this vulnerable population.
33 e needed for parents and care-takers of this vulnerable population.
34 cines, particularly new vaccines, among this vulnerable population.
35 e overall health and quality of life of this vulnerable population.
36 y injury and rapidly divides to replace this vulnerable population.
37 are required to improve oral health in this vulnerable population.
38 o intervening in this difficult to reach yet vulnerable population.
39 vices and should be actively pursued in this vulnerable population.
40 prove the evidence base and outcomes in this vulnerable population.
41 tions attempting to improve outcomes in this vulnerable population.
42 large, endogenous fecal zinc losses, in this vulnerable population.
43 tailored interventions in this anatomically vulnerable population.
44 to advance equitable GFR assessment in this vulnerable population.
45 ial for improving health care access in this vulnerable population.
46 ted research about the mental health of this vulnerable population.
47 ing the unique challenges in testing in this vulnerable population.
48 ons that aim to reduce violent crime in this vulnerable population.
49 fective risk-reducing interventions for this vulnerable population.
50 oncerns regarding the health and safety of a vulnerable population.
51 ty risk is poorly understood in this already vulnerable population.
52 disciplinary, and high-quality care for this vulnerable population.
53 decision-making practices for this medically vulnerable population.
54 ose clinical monitoring is indicated in this vulnerable population.
55 t fostemsavir as a treatment option for this vulnerable population.
56 sion and other psychiatric disorders in this vulnerable population.
57 o transplantation, disadvantaging an already vulnerable population.
58 e ramipril's impact on COVID-19 risk in this vulnerable population.
59 e risk factors for RF and fatal illness in a vulnerable population.
60 uable diagnostic and prognostic tool in this vulnerable population.
61 ldren, but no vaccine exists to protect this vulnerable population.
62 the T cell compartment in early life in this vulnerable population.
63 opportunities to improve LT access for this vulnerable population.
64 ocus attention on high-risk periods for this vulnerable population.
65 firm recommendations on how to protect this vulnerable population.
66 s emphasize the need to closely monitor this vulnerable population.
67 e the full range of medical outcomes in this vulnerable population.
68 ents is needed to improve management of this vulnerable population.
69 out dementia-an understudied but potentially vulnerable population.
70 ce of new cancer treatments, particularly in vulnerable populations.
71 on for residential heating adversely affects vulnerable populations.
72 particular among real-world susceptible and vulnerable populations.
73 of year and changes in affective control in vulnerable populations.
74 ion management may disproportionately affect vulnerable populations.
75 signed to support improved birth outcomes in vulnerable populations.
76 in significant morbidity and mortality among vulnerable populations.
77 rdiac monitoring are needed, particularly in vulnerable populations.
78 re the risks associated with iAs exposure in vulnerable populations.
79 stage and the study of established drugs in vulnerable populations.
80 implementation, and assessment of spatially vulnerable populations.
81 prevention and treatment interventions among vulnerable populations.
82 g pregnant women are needed, particularly in vulnerable populations.
83 ty, worsening food insecurity among the most vulnerable populations.
84 gate the risk of severe disease and death in vulnerable populations.
85 a disproportionate share of medical care to vulnerable populations.
86 ls, but poses a significant health threat to vulnerable populations.
87 lth, inflammation, and infectious disease in vulnerable populations.
88 o produce systematically larger variation in vulnerable populations.
89 ance bias due to barriers to diagnosis among vulnerable populations.
90 ome groups or require tailoring for specific vulnerable populations.
91 able for protection against WNV infection in vulnerable populations.
92 arch to identify effective interventions for vulnerable populations.
93 ead is crucial to management of infected and vulnerable populations.
94 ive collection methods may improve access to vulnerable populations.
95 g as a powerful tool for health promotion in vulnerable populations.
96 ence to screening guidelines, especially for vulnerable populations.
97 cause significant morbidity and mortality in vulnerable populations.
98 tial abuse of and dependence on modafinil in vulnerable populations.
99 l policies on scaling up LPG stove use among vulnerable populations.
100 ences in care may improve cancer outcomes in vulnerable populations.
101 effective method for detecting sleepiness in vulnerable populations.
102 ease respiratory and cardiac morbidity among vulnerable populations.
103 ssion is to care for the uninsured and other vulnerable populations.
104 cally and horizontally integrated system for vulnerable populations.
105 re relatively low, and disparities exist for vulnerable populations.
106 utcome research can be better generalized to vulnerable populations.
107 ofound effect on the health and nutrition of vulnerable populations.
108 f these factors is imperative, especially in vulnerable populations.
109 graphic strata, particularly within socially vulnerable populations.
110 tant public health concern, especially among vulnerable populations.
111 get resources and interventions for the most vulnerable populations.
112 tal solutions, and equity and inclusivity of vulnerable populations.
113 tions to these and other health crises among vulnerable populations.
114 for protecting the health of one of our most vulnerable populations.
115 ), the largest US system of primary care for vulnerable populations.
116 operative outcomes persist, particularly for vulnerable populations.
117 t and can have low efficacy, particularly in vulnerable populations.
118 f significant and irreversible disability in vulnerable populations.
119 xiety, but poses ethical issues when testing vulnerable populations.
120 needed to ensure safe and equitable care for vulnerable populations.
121 reduce the rate of respiratory infections in vulnerable populations.
122 ve health outcomes and reduce disparities in vulnerable populations.
123 health concern, particularly among medically vulnerable populations.
124 ution of the tuberculosis burden in the most vulnerable populations.
125 t programs may penalize practices that serve vulnerable populations.
126 rventions are needed to engage and treat all vulnerable populations.
127 tantiating the need for reducing exposure in vulnerable populations.
128 aths and the spread of infectious disease in vulnerable populations.
129 nabled interventions can reduce attrition in vulnerable populations.
130 surrogate for predicting clinical risk among vulnerable populations.
131 improve the identification and protection of vulnerable populations.
132 en that causes significant morbidity in some vulnerable populations.
133 ting to a moderate increase in protection in vulnerable populations.
134 ures and associated health risks among these vulnerable populations.
135 lized prevention strategies of LOS in highly vulnerable populations.
136 may act as an additional stressor to already vulnerable populations.
137 detrimental health effects, especially among vulnerable populations.
138 ethods to evaluate interventions in the same vulnerable populations.
139 rventions are needed to engage and treat all vulnerable populations.
140 on a national level may further serve these vulnerable populations.
141 xposures are needed to reduce LRTI burden in vulnerable populations.
142 ed for humanitarian interventions to protect vulnerable populations.
143 k helps to target interventions for the most vulnerable populations.
144 prevention of several infectious diseases in vulnerable populations.
145 supplementing iron-replete members of these vulnerable populations.
146 del of engagement in critical care and other vulnerable populations.
147 Health Services Use and Behavioral Model for Vulnerable Populations.
148 o search for other examples of engagement in vulnerable populations.
149 providing affordable coverage to low-income, vulnerable populations.
150 PPIs may have unwanted side effects in vulnerable populations.
152 Fm should also consider the effect on use in vulnerable populations, access to malaria diagnostics, a
154 and family engagement is occurring in other vulnerable populations although there are few described
156 lence and seroprevalence in this potentially vulnerable population and by evaluating biosecurity risk
157 ts indicate Shanchol was immunogenic in this vulnerable population and that a single dose alone may b
158 g data indicate that they are a particularly vulnerable population and underscore the need for furthe
159 an increase in arrhythmia propensity in this vulnerable population and warrants further investigation
160 ncome patients could discourage treatment of vulnerable populations and create substantial downstream
162 ance of maintaining genome-wide variation in vulnerable populations and has direct implications for o
163 te treatment, which pose an urgent threat to vulnerable populations and jeopardise progress and inves
164 icking, provide trauma-informed care to this vulnerable population, and respond to exploited persons
165 ing of sedation adverse events, sedation for vulnerable populations, and (in particular) ketamine sed
166 ntifying critical climate-health impacts and vulnerable populations, and has helped integrate health
167 l, lactose, and exogenous hormones; and that vulnerable populations are better nourished by vegetable
168 n effects of armed conflict on non-combatant vulnerable populations are incompletely understood.
169 - and policy-level interventions that target vulnerable populations are needed to reduce underuse.
171 ions, and measurement of the extent to which vulnerable populations are reached must be assessed for
173 e transfeminine gender identity, represent a vulnerable population at risk for negative mental health
174 ioids, but there is little information about vulnerable populations at high risk of opioid abuse and
175 patients with HER2-positive IBC to identify vulnerable populations at risk of treatment failure.
176 ansmission and significant mortality in this vulnerable population but little broader spread, whereas
177 isks for health and wellbeing, especially in vulnerable populations but ultimately for everybody.
178 thamine provides substantial benefit to this vulnerable population, but resistance to the drugs will
179 (AYA) with cancer have been designated as a vulnerable population by the National Cancer Institute.
180 ses a huge health burden on the world's most vulnerable populations, claiming the lives of nearly one
181 r preparedness activities, informed consent, vulnerable populations, confidentiality, participant bur
182 index, compliance, etc], sparse data on key vulnerable populations (dark-skinned persons, reproducin
183 ddiction; however, little is known about how vulnerable populations differ from those that are relati
184 enting hypovitaminosis D, particularly among vulnerable populations during the winter, whereas supple
185 ignificantly inhibit ThTR-2, particularly in vulnerable populations (e.g., individuals with alcoholis
186 s, the impact will disproportionately affect vulnerable populations, e.g., Hispanic/Latino population
187 mportant to recognize the variability in the vulnerable populations exposed to hazards and to develop
188 onary infections in smokers, ex-smokers, and vulnerable populations exposed to secondhand smoke.
192 duals with HIV infection constitute a highly vulnerable population for MRSA colonization, and prior e
193 of concerns about pregnant patients being a vulnerable population for research, there is little evid
195 ordable and reliable, allowing monitoring of vulnerable populations from the comfort of their homes.
197 cal ethical concerns implicated by the often vulnerable populations from which donors are drawn.
201 ous effects of long-term RV apical pacing in vulnerable populations has created tremendous interest i
202 be considered in special situations in which vulnerable populations have marked deficiency in dietary
203 rmine safe levels of cannabinoid exposure in vulnerable populations (i.e. children and adolescents).
204 iral drug performance, including in the most vulnerable populations (i.e., the aged) using standard l
205 ed but not eliminated such infection in this vulnerable population, implying that non-patient reservo
207 ebellar circuitry and function, constitute a vulnerable population in many human genetic, malignant,
208 h with special healthcare needs constitute a vulnerable population in need of comprehensive and acces
209 prospect of scaling up improved care to this vulnerable population in settings with low resources.
210 mmunity actively engage in and recruit these vulnerable populations in basic research through a strat
211 es to reach and vaccinate children and other vulnerable populations in conflict settings, outbreaks o
212 e identify known and previously unidentified vulnerable populations in cortical layer 5 and show that
214 on recent discussions and research regarding vulnerable populations in medicine, including patients w
218 ge declined, with disproportionate impact on vulnerable populations including older, Black, and lower
220 ndereducated about the lives and concerns of vulnerable populations, including LGBTQI persons, immigr
221 th challenge that disproportionately affects vulnerable populations, including older people, immunoco
222 ulent drug-resistant strains or movements of vulnerable populations, including those in conflict zone
223 substantial harmful chemical exposures among vulnerable populations, including women and children.
224 mptoms in currently depressed adults and two vulnerable populations: individuals remitted from depres
225 luded 169 daily smokers from the following 3 vulnerable populations: individuals with affective disor
226 nd bone fractures, and the identification of vulnerable populations is important to clinical practice
228 aracterized endocrine-disrupting chemical-to vulnerable populations is representative of systemic pro
229 mically disadvantaged or being a member of a vulnerable population may be the first steps toward spec
230 ng underlying coronary heart disease in this vulnerable population may help target therapies that cou
231 extent of public restraint and cocooning of vulnerable populations may save or cost thousands of liv
232 research establishing the immune history of vulnerable populations, modeling when and where the next
234 performed on children reveals an especially vulnerable population needing special protection against
236 st that hypoalbuminemia at listing reveals a vulnerable population of low MELD patients who are under
237 y-net hospitals provide broad services for a vulnerable population of patients and are financially at
238 wn of a wider network rather than a discrete vulnerable population of specialised motor neurons.
239 ute respiratory infections are widespread in vulnerable populations of all ages and are characterized
240 ant gene products cause dysfunction/death of vulnerable populations of nerve cells important in memor
241 mises the long-term viability of selectively vulnerable populations of neurons in frontal cortices th
242 s pandemic to create large and significantly vulnerable populations of patients with COVID-19 and dia
244 evalence of Mycoplasma genitalium is high in vulnerable populations of women in low-resource settings
246 ses are associated with high morbidity among vulnerable populations, particularly immunocompromised p
247 of maternal mortality, seen most acutely in vulnerable populations, predominantly in sub-Saharan Afr
249 ent (IPT) with sulphadoxine-pyrimethamine in vulnerable populations reduces malaria morbidity in Afri
251 ated urban communities, usually inhabited by vulnerable populations, require further reductions of to
252 urce-limited settings, where the majority of vulnerable populations reside and where the incidence of
253 ly, the data suggest that clonal spread in a vulnerable population resulted from extensive clinical i
254 ists agreed more strongly than patients that vulnerable populations should be included in research.
255 rts to reduce treatment disparities in these vulnerable populations should target systems improvement
256 y 5-10% of cerebellar Purkinje cells, a less vulnerable population, showed the same statistically sig
257 bute to raising cancer risks, especially for vulnerable populations such as children and communities
258 biology, and to reduce radiation exposure to vulnerable populations such as children and women of chi
260 ent risk assessment practices and to protect vulnerable populations such as pregnant women and childr
261 d children.IMPORTANCE The ability to protect vulnerable populations such as pregnant women and childr
262 us health concern worldwide, particularly in vulnerable populations such as the immunocompromised, el
263 ed financial strain from the BBA and whether vulnerable populations such as the uninsured were dispro
265 e has raised concern regarding its impact on vulnerable populations, such as pregnant women and adole
266 laxis or treatment of arbovirus infection in vulnerable populations, such as pregnant women and child
267 S and euthanasia present potential risks for vulnerable populations, such as the depressed and disabl
269 ally ill children and adolescents comprise a vulnerable population that requires specific considerati
270 ing immune responses and can be delivered to vulnerable populations that are unable to receive live-a
271 gnificantly reduced hospitalization rates in vulnerable populations, the current vaccines are estimat
272 and with unlimited advertising geared toward vulnerable populations, the groups most likely to smoke
273 health opportunity to promote health in this vulnerable population; the costs to the individual and t
274 also improve democratic institutions so that vulnerable populations themselves can push their represe
275 with the mission of preventing typhoid among vulnerable populations through research, education, and
276 cores the need for special attention to this vulnerable population to ensure that imaging is appropri
277 nt implications for treating one of the most vulnerable populations to anxiety and stress related dis
278 th measures targeting specific locations and vulnerable populations to mitigate the current opioids c
279 d water treatment (HWT) provides a means for vulnerable populations to take charge of their own drink
280 ork City, where the density of emissions and vulnerable populations vary greatly, we simulated the ai
282 e the goals for the medical care for certain vulnerable populations.Vulnerable populations are at ris
283 at may impart an increased risk for a highly vulnerable population, whereby pubertal programming of t
284 sure access to appropriate services for this vulnerable population, which provides opportunities for
285 es the impact of LCS eligibility criteria on vulnerable populations who are at increased risk of lung
286 ly benefiting rural populations and socially vulnerable populations widely distributed in each urban
287 afety and efficacy of these vaccines in this vulnerable population will be important to document.
288 including outpatient costs and eye trauma in vulnerable populations will be key to optimizing care an
290 y effects of air pollution in the elderly--a vulnerable population with low reserve capacity--and mec
291 human immunodeficiency virus (HIV) and other vulnerable populations with legal means of redress again
293 nership has established goals for protecting vulnerable populations with locally appropriate vector c
297 ealth disparities among several historically vulnerable populations, with stark differences in the pr
298 t that expanded methadone access may benefit vulnerable populations without harming overall retention